Exparel as a Nerve Block for Severe Hand Pain

Last updated: April 24, 2024
Sponsor: Jose Soberon, MD
Overall Status: Terminated

Phase

2/3

Condition

Peripheral Vascular Disease

Scleroderma

Vascular Diseases

Treatment

liposomal bupivacaine

Clinical Study ID

NCT02374320
2014.155.C
  • Ages > 18
  • All Genders

Study Summary

The purpose of this study is to investigate whether the use of the study drug (Exparel) is safe and effective for treating circulation problems and pain in the hand or fingers.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • American Society of Anesthesiologists (ASA) status I-IV

Exclusion

Exclusion Criteria:

  • True Allergy, not sensitivity to: local anesthetics, midazolam, fentanyl, propofol,ketamine

  • Previous surgery or significant trauma involving the radial or ulnar arteries (previous history of angiography and intravascular catheter placement are permitted)

  • Pregnancy

  • Severe hepatic impairment

  • Evidence of infection at or near the proposed needle insertion site

  • Any sensorimotor deficit of the ipsilateral upper extremity, whether acute orchronic as determined by the PI and/or designee

Study Design

Total Participants: 13
Treatment Group(s): 1
Primary Treatment: liposomal bupivacaine
Phase: 2/3
Study Start date:
November 01, 2014
Estimated Completion Date:
March 31, 2016

Connect with a study center

  • Ochsner Clinic Foundation

    New Orleans, Louisiana 70121
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.